| Behavior of neoplasm | 코드 | 조직학적 진단명 | 2016년 | 2015년 | 전년대비 증감율 |
||
|---|---|---|---|---|---|---|---|
| 건수 | 구성비 | 건수 | 구성비 | ||||
| Carcinoma in situ (정상소재암) |
M80102 | Carcinoma in situ, NOS | 6 | 0.35 | 9 | 0.57 | -33.3 |
| M80702 | Squamous cell carcinoma in situ, NOS | 9 | 0.52 | 22 | 1.39 | -59.1 | |
| M80772 | CIN III with severe dysplasia(C53._) | 16 | 0.93 | 7 | 0.44 | 128.6 | |
| M80812 | Bowen disease(C44._) | 2 | 0.12 | 2 | 0.13 | 0.0 | |
| M81202 | Transitional cell carcinoma in situ | 3 | 0.17 | 6 | 0.38 | -50.0 | |
| M81302 | Papillary transitional cell carcinoma, non-invasive(C67._) | 23 | 1.33 | 25 | 1.58 | -8.0 | |
| M81402 | Adenocarcinoma in situ, NOS | 8 | 0.46 | 5 | 0.32 | 60.0 | |
| M82012 | Ductal carcinoma in situ, cribriform type(C50._) | 1 | 0.06 | 2 | 0.13 | -50.0 | |
| M82102 | Adenocarcinoma in situ in tubular adenoma | 1 | 0.06 | ||||
| M82112 | Tubular adenocarcinoma in situ | 1 | 0.06 | 2 | 0.13 | -50.0 | |
| M82302 | Ductal carcinoma in situ, solid type(C50._) | 1 | 0.06 | 2 | 0.13 | -50.0 | |
| M82612 | Adenocarcinoma in situ in villous adenoma | 1 | 0.06 | ||||
| M82632 | Adenocarcinoma in situ in tubulovillous adenoma | 2 | 0.12 | 4 | 0.25 | -50.0 | |
| M85002 | Ductal carcinoma in situ, NOS(C50._) | 2 | 0.12 | 3 | 0.19 | -33.3 | |
| M85012 | Ductal carcinoma in situ, comedo type(C50._) | 1 | 0.06 | 5 | 0.32 | -80.0 | |
| M85032 | Intraductal papillary neoplasm with high grade intraepithelial neoplasia | 3 | 0.17 | 1 | 0.06 | 200.0 | |
| M85072 | Intraductal micropapillary carcinoma(C50._) | 2 | 0.12 | ||||
| M85202 | Lobular carcinoma in situ, NOS(C50._) | 2 | 0.12 | 1 | 0.06 | 100.0 | |
| Carcinoma in situ 합계 | 84 | 4.88 | 96 | 6.07 | -12.5 | ||
| Malignant, primary site (악성, 원발부위암) |
M80003 | Malignant neoplasm, NOS | 291 | 16.89 | 265 | 16.75 | 9.8 |
| M80103 | Carcinoma, NOS | 15 | 0.87 | 10 | 0.63 | 50.0 | |
| M80133 | Large cell neuroendocrine carcinoma | 2 | 0.12 | ||||
| M80203 | Carcinoma, undifferentiated, NOS | 2 | 0.12 | ||||
| M80213 | Carcinoma, anaplastic, NOS | 1 | 0.06 | -100.0 | |||
| M80333 | Pseudosarcomatous carcinoma | 2 | 0.12 | 4 | 0.25 | -50.0 | |
| M80413 | Small cell carcinoma, NOS | 12 | 0.70 | 27 | 1.71 | -55.6 | |
| M80463 | Non-small cell carcinoma(C34._) | 15 | 0.87 | 16 | 1.01 | -6.3 | |
| M80523 | Papillary squamous cell carcinoma | 1 | 0.06 | -100.0 | |||
| M80703 | Squamous cell carcinoma, NOS | 95 | 5.51 | 101 | 6.38 | -5.9 | |
| M80713 | Squamous cell carcinoma, keratinizing, NOS | 8 | 0.46 | 6 | 0.38 | 33.3 | |
| M80723 | Squamous cell carcinnoma, large cell, nonkeratinizing, NOS | 10 | 0.58 | 5 | 0.32 | 100.0 | |
| M80763 | Squamous cell carcinoma, microinvasive | 2 | 0.12 | ||||
| M80833 | Basaloid squamous cell carcinoma | 1 | 0.06 | ||||
| M80903 | Basal cell carcinoma, NOS(C44._) | 6 | 0.35 | 12 | 0.76 | -50.0 | |
| M81203 | Transitional cell carcinoma, NOS | 37 | 2.15 | 30 | 1.90 | 23.3 | |
| M81303 | Papillary transitional cell carcinoma (C67._) | 19 | 1.10 | 13 | 0.82 | 46.2 | |
| M81403 | Adenocarcinoma, NOS | 328 | 19.04 | 339 | 21.43 | -3.2 | |
| M81443 | Adenocarcinoma, intestinal type(C16._) | 1 | 0.06 | ||||
| M81473 | Basal cell adenocarcinoma | 1 | 0.06 | -100.0 | |||
| M81603 | Cholangiocarcinoma(C22.1, C24.0) | 46 | 2.67 | 31 | 1.96 | 48.4 | |
| M81623 | Klatskin tumor(C22.1, C24.0) | 13 | 0.75 | 3 | 0.19 | 333.3 | |
| M81703 | Hepatocellular carcinoma, NOS(C22.0) | 103 | 5.98 | 101 | 6.38 | 2.0 | |
| M81743 | Hepatocellular carcinoma, clear cell type(C22.0) | 1 | 0.06 | ||||
| M82003 | Adenoid cystic carcinoma | 3 | 0.17 | ||||
| M82013 | Cribriform carcinoma, NOS | 1 | 0.06 | ||||
| M82103 | Adenocarcinoma in tubular adenoma | 9 | 0.52 | 7 | 0.44 | 28.6 | |
| M82113 | Tubular adenocarcinoma | 78 | 4.53 | 77 | 4.87 | 1.3 | |
| M82303 | Solid carcinoma, NOS | 2 | 0.12 | 2 | 0.13 | 0.0 | |
| M82403 | Neuroendocrine tumor, grade 1 | 7 | 0.41 | 3 | 0.19 | 133.3 | |
| M82463 | Neuroendocrine carcinoma, NOS | 8 | 0.46 | 3 | 0.19 | 166.7 | |
| M82473 | Merkel cell carcinoma(C44._) | 1 | 0.06 | ||||
| M82493 | Neuroendocrine tumor, grade 2 | 2 | 0.12 | 1 | 0.06 | 100.0 | |
| M82603 | Papillary adenocarcinoma, NOS | 116 | 6.73 | 114 | 7.21 | 1.8 | |
| M82633 | Adenocarcinoma in tubulovillous adenoma | 10 | 0.58 | 6 | 0.38 | 66.7 | |
| M82653 | Micropapillary carcinoma, NOS (C18._, C19.9, C20.9) | 1 | 0.06 | -100.0 | |||
| M83103 | Clear cell adenocarcinoma, NOS | 1 | 0.06 | 3 | 0.19 | -66.7 | |
| M83123 | Renal cell carcinoma, NOS(C64.9) | 37 | 2.15 | 13 | 0.82 | 184.6 | |
| M83173 | Renal cell carcinoma, chromophobe type(C64.9) | 1 | 0.06 | 2 | 0.13 | -50.0 | |
| M83233 | Mixed cell adenocarcinoma | 0.00 | 1 | 0.06 | -100.0 | ||
| M83303 | Follicular adenocarcinoma, NOS(C73.9) | 2 | 0.12 | 2 | 0.13 | 0.0 | |
| M83403 | Papillary carcinoma, follicular variant(C73.9) | 5 | 0.29 | ||||
| M83703 | Adrenal cortical carcinoma(C74.0) | 0.00 | 1 | 0.06 | -100.0 | ||
| M83803 | Endometrioid carcinoma, NOS | 6 | 0.35 | 7 | 0.44 | -14.3 | |
| M83843 | Adenocarcinoma, endocervical type | 0.00 | 2 | 0.13 | -100.0 | ||
| M84103 | Sebaceous carcinoma(C44._) | 1 | 0.06 | ||||
| M84303 | Mucoepidermoid carcinoma | 2 | 0.12 | 2 | 0.13 | 0.0 | |
| M84413 | Serous adenocarcinoma, NOS | 7 | 0.41 | 3 | 0.19 | 133.3 | |
| M84533 | Intraductal papillary-mucinous carcinoma, invasive(C25._) | 3 | 0.19 | -100.0 | |||
| M84603 | Papillary serous cystadenocarcinoma(C56.9) | 3 | 0.19 | -100.0 | |||
| M84613 | Serous surface papillary carcinoma(C56.9) | 1 | 0.06 | -100.0 | |||
| M84703 | Mucinous cystadenocarcinoma, NOS(C56.9) | 1 | 0.06 | -100.0 | |||
| M84803 | Mucinous adenocarcinoma | 11 | 0.64 | 10 | 0.63 | 10.0 | |
| M84903 | Signet ring cell carcinoma | 22 | 1.28 | 30 | 1.90 | -26.7 | |
| M85003 | Infiltrating duct carcinoma, NOS(C50._) | 73 | 4.24 | 72 | 4.55 | 1.4 | |
| M85103 | Medullary carcinoma, NOS | 1 | 0.06 | -100.0 | |||
| M85123 | Medullary carcinoma with lymphoid stroma | 1 | 0.06 | ||||
| M85203 | Lobular carcinoma, NOS(C50._) | 5 | 0.29 | 7 | 0.44 | -28.6 | |
| M85233 | Infiltrating duct and tubular carcinoma(C50._) | 2 | 0.12 | ||||
| M85413 | Paget disease and infiltrating duct carcinoma of breast(C50._) | 1 | 0.06 | -100.0 | |||
| M85423 | Paget disease, extramammary (for all sites except breast) | 1 | 0.06 | ||||
| M85503 | Acinar cell carcinoma | 54 | 3.13 | 32 | 2.02 | 68.8 | |
| M85603 | Adenosquamous carcinoma | 5 | 0.29 | ||||
| M85803 | Thymoma, malignant, NOS(C37.9) | 2 | 0.12 | ||||
| M85813 | Thymoma, type A, malignant(C37.9) | 1 | 0.06 | -100.0 | |||
| M85823 | Thymoma type AB, malignant(C37.9) | 1 | 0.06 | ||||
| M85833 | Thymoma, type B1, malignant(C37.9) | 1 | 0.06 | ||||
| M85843 | Thymoma, type B2, malignant(C37.9) | 1 | 0.06 | -100.0 | |||
| M85853 | Thymoma, type B3, malignant(C37.9) | 1 | 0.06 | ||||
| M86203 | Granulosa cell carcinoma(C56.9) | 1 | 0.06 | ||||
| M87203 | Malignant melanoma, NOS (except jubenile melanoma M-8770/0) | 5 | 0.29 | 5 | 0.32 | 0.0 | |
| M87213 | Nodular melanoma(C44._) | 2 | 0.12 | ||||
| M88003 | Sarcoma, NOS | 3 | 0.17 | ||||
| M88023 | Pleomorphic cell sarcoma | 1 | 0.06 | -100.0 | |||
| M88033 | Small cell sarcoma | 1 | 0.06 | ||||
| M88053 | Undifferentiated sarcoma | 1 | 0.06 | ||||
| M88113 | Fibromyxosarcoma | 1 | 0.06 | ||||
| M88153 | Solitary fibrous tumor, malignant | 1 | 0.06 | -100.0 | |||
| M88303 | Malignant fibrous histiocytoma | 1 | 0.06 | ||||
| M88323 | Dermatofibrosarcoma, NOS(C44._) | 1 | 0.06 | ||||
| M88503 | Liposarcoma, NOS | 1 | 0.06 | -100.0 | |||
| M88513 | Liposarcoma, well differentiated | 2 | 0.12 | ||||
| M88523 | Myxoid liposarcoma | 2 | 0.13 | -100.0 | |||
| M88583 | Dedifferentiated liposarcoma | 2 | 0.12 | ||||
| M89333 | Adenosarcoma | 1 | 0.06 | -100.0 | |||
| M89363 | Gastrointestinal stromal sarcoma | 13 | 0.75 | 6 | 0.38 | 116.7 | |
| M89803 | Carcinosarcoma, NOS | 4 | 0.25 | -100.0 | |||
| M90503 | Mesothelioma, malignant | 2 | 0.12 | 3 | 0.19 | -33.3 | |
| M90613 | Seminoma, NOS(C62._) | 1 | 0.06 | ||||
| M90643 | Germinoma | 1 | 0.06 | -100.0 | |||
| M90853 | Mixed germ cell tumor | 2 | 0.13 | -100.0 | |||
| M91203 | Hemangiosarcoma | 3 | 0.17 | 1 | 0.06 | 200.0 | |
| M91503 | Hemangiopericytoma, malignant | 1 | 0.06 | ||||
| M91803 | Osteosarcoma, NOS(C40._, C41._) | 1 | 0.06 | 2 | 0.13 | -50.0 | |
| M92203 | Chondrosarcoma, NOS(C40._, C41_) | 1 | 0.06 | -100.0 | |||
| M92603 | Ewing sarcoma | 1 | 0.06 | ||||
| M93643 | Neuroectodermal tumor, NOS | 1 | 0.06 | ||||
| M93923 | Ependymoma, anaplastic(C71._) | 1 | 0.06 | ||||
| M94003 | Astrocytoma, NOS(C71._) | 2 | 0.12 | 1 | 0.06 | 100.0 | |
| M94013 | Astrocytoma, anaplastic(C71._) | 1 | 0.06 | 3 | 0.19 | -66.7 | |
| M94203 | Fibrillary astrocytoma(C71._) | 1 | 0.06 | -100.0 | |||
| M94403 | Glioblastoma, NOS(C71._) | 11 | 0.64 | 6 | 0.38 | 83.3 | |
| M94513 | Oligodendroglioma, anaplastic(C71._) | 1 | 0.06 | ||||
| M94703 | Medulloblastoma, NOS(C71.6) | 1 | 0.06 | ||||
| M94723 | Medullomyoblastoma(C71.6) | 1 | 0.06 | ||||
| M95303 | Meningioma, anaplastic | 1 | 0.06 | ||||
| M95403 | Malignant peripheral nerve sheath tumor | 1 | 0.06 | ||||
| M95903 | Malignant lymphoma, NOS | 5 | 0.29 | 1 | 0.06 | 400.0 | |
| M95913 | B cell lymphoma, NOS | 1 | 0.06 | ||||
| M96503 | Hodgkin lymphoma, NOS | 2 | 0.12 | ||||
| M96523 | Hodgkin lymphoma, mixed cellularity, NOS | 2 | 0.12 | 1 | 0.06 | 100.0 | |
| M96533 | Hodgkin lymphoma, lymphocyte depletion, NOS | 2 | 0.13 | -100.0 | |||
| M96733 | Mantle cell lymphoma(includes all variant: blastic, pleomorphic, small cell) | 1 | 0.06 | 3 | 0.19 | -66.7 | |
| M96793 | Mediastinal large B-cell lymphoma(C38.3) | 1 | 0.06 | ||||
| M96803 | Malignant lymphoma, large B-cell, diffuse, NOS | 19 | 1.10 | 17 | 1.07 | 11.8 | |
| M96873 | Burkitt lymphoma, NOS | 1 | 0.06 | ||||
| M96883 | T-cell/histiocyte rich large B-cell lymphoma | 1 | 0.06 | -100.0 | |||
| M96903 | Follicular lymphoma, NOS | 1 | 0.06 | -100.0 | |||
| M96913 | Follicular lymphoma, grade 2 | 1 | 0.06 | ||||
| M96983 | Folloicular lymphoma, grade 3 | 2 | 0.12 | 1 | 0.06 | 100.0 | |
| M96993 | Marginal zone B-cell lymphoma, NOS | 1 | 0.06 | 5 | 0.32 | -80.0 | |
| M97023 | Mature T-cell lymphoma, NOS | 4 | 0.23 | 1 | 0.06 | 300.0 | |
| M97053 | Angioimmunoblastic T-cell lymphoma | 2 | 0.12 | ||||
| M97193 | NK/T-cell lymphoma, nasal and nasal-type | 1 | 0.06 | ||||
| M97253 | Hydroa vacciniforme-like lymphoma | 1 | 0.06 | ||||
| M97313 | Plasmacytoma, NOS | 5 | 0.29 | 2 | 0.13 | 150.0 | |
| M97323 | Multiple myeloma(C42.1) | 13 | 0.75 | 5 | 0.32 | 160.0 | |
| M97513 | Langerhans cell histiocytosis, NOS | 2 | 0.13 | -100.0 | |||
| M97553 | Histiocytic sarcoma | 1 | 0.06 | -100.0 | |||
| M97613 | Waldenstrom macroglobulinemia(C42.0) | 1 | 0.06 | -100.0 | |||
| M98003 | Leukemia, NOS | 3 | 0.17 | 3 | 0.19 | 0.0 | |
| M98013 | Acute leukemia, NOS | 2 | 0.12 | 4 | 0.25 | -50.0 | |
| M98603 | Myeloid leukemia, NOS | 2 | 0.13 | -100.0 | |||
| M98613 | Acute myeloid leukemia, NOS | 3 | 0.17 | 1 | 0.06 | 200.0 | |
| M98633 | Chronic myeloid leukemia, NOS | 2 | 0.12 | 2 | 0.13 | 0.0 | |
| M98723 | Acute myeloblastic leukemia | 1 | 0.06 | 2 | 0.13 | -50.0 | |
| M99303 | Myeloid sarcoma | 1 | 0.06 | 2 | 0.13 | -50.0 | |
| M99313 | Acute panmyelosis with myelofibrosis(C42.1) | 1 | 0.06 | -100.0 | |||
| M99403 | Hairy cell leukemia variant | 1 | 0.06 | ||||
| M99453 | Chronic myelomonocytic leukemia, NOS | 1 | 0.06 | 1 | 0.06 | 0.0 | |
| M99503 | Polycythemia vera | 2 | 0.12 | ||||
| M99613 | Primary myelofibrosis | 1 | 0.06 | -100.0 | |||
| M99623 | Essential thrombocythemia | 2 | 0.12 | ||||
| M99803 | Refractory anemia | 1 | 0.06 | ||||
| M99833 | Refractory anemia with excess of blasts | 1 | 0.06 | ||||
| M99853 | Refractory cytopenia with multilineage dysplasia | 2 | 0.12 | ||||
| M99893 | Myelodysplastic syndrome, NOS | 5 | 0.29 | 2 | 0.13 | 150.0 | |
| Malignant, primary site 합계 | 1,639 | 95.12 | 1,486 | 93.93 | 10.3 | ||
| 총합계 | 1,723 | 100.00 | 1,582 | 100.00 | 8.9 | ||